Scott Becker, founder and Publisher of Becker’s Hopital Review, asks CEO, Diana Peninger, how her expertise in engineering and chemistry helps drive fertility innovation at RSI. Plus, listen to Diana and Scott share personal stories of assisted fertility experiences.
Becker’s Healthcare platform is the go-to source for healthcare decision makers around the nation and one of the fastest growing media platforms in the industry, with over 2.8 million visitors a month.
All ProteX claims of improved semen quality are made comparing collection in ProteX to collection in a standard specimen cup, and are based on published study data. Results using ProteX will vary by each patient and are affected by a number of uncontrolled factors, including and not limited to the patient’s age, diagnosis, lifestyle, diet, and genetics. Reproductive Solutions makes no guarantee of pregnancy outcomes when using ProteX. ProteX is a registered trademark of Reproductive Solutions.
Patent US 6,864,046 B1, Patent: US 17/364,792, PCT/US2021/040017 Ctrl# PTX-MMTL-20044 rev. 00
© 2024 Reproductive Solutions.
